Botanix presentation at Bell Potter Healthcare Conference

/in , , , /by

Botanix Founder and Board Executive Director Matt Callahanwill be a featured presenter at the Bell Potter Healthcare Conference 2024 on Tuesday, 19 November. A copy of the presentation being used is attached to the ASX press release.

View ASX release.

Botanix adds Payer coverage representing ~65 million commercial lives

/in , , , /by

Ascent Health, second largest Payer (insurer) organisation in the US, will now cover Sofdra™ (sofpironium) topical gel, 12.45%. Ascent represents approximately 65 million (or nearly 40%) of US commercial lives.

View release.